apricitabine

DRUG5 trials

Sponsors

Avexa

Conditions

HIV InfectionHIV Infections

Phase 1

A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects

CompletedNCT00334659

AvexaHIV Infections

Start: 2006-06-30End: 2006-08-31Updated: 2011-06-23

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

CompletedNCT00352066

AvexaHIV Infection

Start: 2006-07-31End: 2006-08-31Updated: 2011-06-23

Phase 2

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

CompletedNCT00367952

AvexaHIV Infection

Start: 2006-08-31End: 2010-01-31Updated: 2011-06-23

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

TerminatedNCT00612898

AvexaHIV Infections

Start: 2008-02-29End: 2010-01-31Updated: 2012-01-23

Phase 3

A Long Term Safety Study of Apricitabine in HIV-infected Patients

WithdrawnNCT00686270

AvexaHIV Infections

Start: 2008-05-31End: 2012-05-31Updated: 2011-06-23